Matrix metalloproteinase expression during experimental autoimmune neuritis

Brain

Volumn 121, Issue 3, 1998, Pages 481-494

  Hughes, P M ^a   Wells, G M A ^b   Clements, J M ^b   Gearing, A J H ^b   Redford, E J ^c   Davies, M ^c   Smith, K J ^c   Hughes, R A C ^c   Brown, M C ^a   Miller, K M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

^c UMDS   (United Kingdom)

Author keywords

Experimental autoimmune neuritis; Inflammation; Matrix metalloproteinases; Peripheral nervous system; Tumour necrosis factor alpha

Indexed keywords

ELASTASE; GELATINASE; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENDONEURIUM; ENDOTHELIUM CELL; ENZYME LOCALIZATION; GUILLAIN BARRE SYNDROME; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; NEURITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; SCIATIC NERVE; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; IMMUNOHISTOCHEMISTRY; METALLOENDOPEPTIDASES; NEURITIS; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; REFERENCE VALUES; SCIATIC NERVE; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031950668     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.3.481     Document Type: Article

References (74)

1. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. Neurosci Res 1994; 38: 365-75.
2. Bhattacharyya A, Oppenheim RW, Prevette D, Moore BW, Brackenbury P, Ratner N. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. J Neurobiol 1992; 23: 451-66.
3. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. [Review]. Crit Rev Oral Biol Med 1993; 4: 197-250.
4. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. A metalloproteinase disintegrin that releases tumournecrosis-α from cells. Nature 1997; 385: 729-33.
5. Brosnan CF, Cammer W, Norton WT, Bloom BR. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 1980; 285: 235-7.
6. Bunge, MB. Schwann cell regulation of extracellular matrix biosynthesis and assembly. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd edition. Philadelphia: Saunders; 1993. p. 299-316.
7. Busiek DF, Baragi V, Nehring LC, Parks WC, Welgus HG. Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 1995; 154: 6484-91.
8. Chandler S, Coates R, Gearing A, Lury J, Wells G, Bone E. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 1995; 201: 223-6.
9. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. [Review]. J Neuroimmunol 1997; 72: 155-61.
10. Clements JM, Cossins JA, Wells GM, Corkill DJ, Helfrich K, Wood ML, et al. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-α inhibitor. J Neuroimmunol 1997; 74: 85-94.
11. Dallman MJ, Thomas ML, Green JR. MRC OX-19: a monoclonal antibody that labels T lymphocytes and augments in vitro proliferative responses. Eur J Immunol 1984; 14: 260-7.
12. Damoiseaux JG, Dopp EA, Calame W, Chao W, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994; 83: 140-7.
13. Dijkstra CD, Dopp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by mononuclear antibodies ED1, ED2 and ED3. Immunology 1985; 54: 589-99.
14. Fernandez-Resa P, Mira E, Quesada AR. Enhanced detection of casein zymography of matrix metalloproteinases. Anal Biochem 1995; 224: 434-5.
15. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, et al. Processing of tumour necrosis factor-α precursor by metalloproteinase. Nature 1994; 370: 555-7.
16. Giannini C, Dyck PJ. The fate of Schwann cell basement membranes in permanently transected nerves. J Neuropathol Exp Neurol 1990; 49: 550-63.
17. Gijbels K, Proost P, Masure S, Carton A, Billiau A, Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. Neurosci Res 1993; 36: 432-40.
18. Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteinases. J Clin. Invest 1994; 94: 2177-82.
19. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 1996; 93: 9748-53.
20. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor a, interleukin 1 and phorbol ester. Biochem J 1993, 296: 803-9.
21. Hartung H-P, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, et al. Inflammatory mediators in demyelinating disorders of the CNS and PNS. [Review]. J Neuroimmunol 1992; 40: 197-210.
22. Hartung H-P, Stoll G, Toyka KV. Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders; 1993. p. 418-44.
23. Hartung H-P, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome - part I. [Review]. Muscle Nerve 1995a; 18: 137-53.
24. Hartung H-P, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome - part II. [Review], Muscle Nerve 1995b; 18: 154-64.
25. Harvey GK, Pollard JD. Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum. J Neuroimmunol 1992; 41 159-66.
26. Harvey GK, Gidd R, Hartung H-P, Toyka KV. Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain 1995; 118: 1263-72.
27. Hsu SM, Raine L. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981; 29: 1349-53.
28. Hughes, RA. The concept and classification of Guillain-Barré syndrome and related disorders [editorial]. Rev Neurol (Paris) 1995; 151: 291-4.
29. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995; 270: 6691-7.
30. Kadlubowski M, Hughes RA. Identification of the neuritogen for experimental allergic neuritis. Nature 1979; 277: 140-1.
31. Kadlubowski M, Hughes RA, Gregson NA. Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein, P2. Brain Res 1980; 184: 439-54.
32. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-9.
33. La Fleur M, Underwood JL, Rappolee DA, Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 1996; 184: 2311-26.
34. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995; 154: 4379-89.
35. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur. J Immunol 1992; 22: 1813-7.
36. Manicourt D, Lefebvre V. An assay for matrix metalloproteinases and other proteases acting on proteoglycans, casein, or gelatin. Anal Biochem 1993; 215: 171-9.
37. Matyszak MK, Perry VH. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J Neuroimmunol 1996; 69: 141-9.
38. Moss ML, Jin S-L, Milla ME, Burkhart W, Carter HL, Chen W-J, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385: 733-6.
39. Muir D, Varon S, Manthorpe M. Schwann cell proliferation in vitro is under negative autocrine control. J Cell Biol 1990; 111: 2663-71.
40. Muir D, Manthorpe M. Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation. J Cell Biol 1992; 116: 177-85.
41. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. [Review]. Ann N Y Acad Sci 1993; 667: 1-12.
42. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 1990; 29: 5783-9.
43. Okada Y, Gonoji Y, Naka K, Toita K, Nakanishi I, Iwata K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992; 267: 21712-9.
44. Opdenakker G, Van Damme J. Cytokine-regulated proteases in autoimmune diseases. [Review], Immunol Today 1994; 15: 103-76.
45. Pollard JD, Harrison B, Gatenby P. Serum-induced demyelination: an electrophysiological and histological study. Clin Exp Neurol 1981; 18: 70-80.
46. Powell HC, Braheny SL, Myers RR, Rodriguez M, Lampert PW. Early changes in experimental allergic neuritis. Lab Invest 1983; 48: 332-8.
47. Powell HC, Myers RR, Mizisin AP, Olee T, Brostoff SW. Response of the axon and barrier endothelium to experimental allergic neuritis induced in autoreactive T cell lines. Acta Neuropathol (Berl) 1991; 82: 364-77.
48. Proost P, Van Damme J, Opdenakker G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem Biophys Res Commun 1993; 192: 1175-81.
49. Raine CS, Bornstein MB. (1979) Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures. Lab Invest 1979; 40: 423-32.
50. Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 1995; 118: 869-78.
51. Redford EJ, Smith KJ, Gregson NA, Davies M, Hughes PM, Gearing AJ, et al. A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor alpha processing attenuates experimental autoimmune neuritis. In press. Brain. 1997.
52. Romanic AM, Madri JA. The induction of 72 kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 1994; 125: 1165-78.
53. Rosenberg GA. Matrix metalloproteinases in brain injury. [Review]. J Neurotrauma 1995; 12: 833-41.
54. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, et al. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992; 576: 203-7.
55. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 1992; 703: 151-5.
56. Said G, Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res Immunol 1992; 143: 589-99.
57. Saida T, Saida K, Silberberg DH, Brown MJ. Transfer of demyelination with experimental allergic neuritis serum by intraneural injection of experimental allergic neuritis serum. Nature 1978; 272: 639-41.
58. Saida T, Saida K, Silberberg DH, Brown MJ. Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 1981; 9 Suppl: 87-101.
59. Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157: 4159-65.
60. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 1994; 370: 61-5. Comment in: Nature 1994; 370: 14-5.
61. Schabet M, Whitaker JN, Schott K, Stevens A, Zurn A, Buhler R, et al. The use of protease inhibitors in experimental allergic neuritis. J Neuroimmunol 1991; 31: 265-72.
62. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993; 268: 23824-9.
63. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA 1996; 93: 3942-6.
64. Stoll G, Schmidt B, Jander S, Toyka KV, Hartung H-P. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991; 30: 147-55.
65. Stoll G, Jung S, Jander S, van der Meide P, Hartung HP. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 1993; 45: 175-82.
66. Thomas PK. The deposition of collagen in relation to Schwann cell basement membrane during peripheral nerve regeneration. J Cell Biol 1964; 23: 375-82.
67. Thomas PK. The Guillain-Barré syndrome: no longer a simple concept [editorial]. J Neurol 1992; 239: 361-2.
68. Wadhwani KC, Rapoport SI. Transport properties of vertebrate blood-nerve barrier: comparison with blood-brain barrier. [Review]. Prog Neurobiol 1994; 43: 235-79.
69. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996; 73: 625-9.
70. Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985; 227: 747-9.
71. Wells GM, Catlin G, Cossins JA, Mangan M, Ward GA, Miller KM et al. Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard. Glia 1996; 18: 332-40.
72. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. [Review]. Int J Biochem Cell Biol 1996; 28: 123-36.
73. Woessner JF. Role of cellular proteinases and their proteinase inhibitors in inflammation. In: Whicher JT, Woessner JF editors. Immunology and medicine: biochemistry of inflammation. Dordrecht: Kluwer Academic; 1992. p. 57-89.
74. Zhou H, Bernhard EJ, Fox FE, Billings PC. Induction of metalloproteinase activity in human T lymphocytes. Biochim Biophys Acta 1993; 1177: 174-82.